Skip to content
Search

Latest Stories

PDA raises concern over calls for 'locum blacklist'

The Pharmacists’ Defence Association (PDA) has raised concerns over “a prominent pharmacist’s call to create a sector 'blacklist' for locums regarding disputes over rates.”

A few contractors took it to the Twitter to share screenshots of the messages by locums demanding more pay, which led to the call for ‘blacklisting’ those locums.


“The motivation regarding the current talk of creating a blacklist seems intrinsically tied to hourly rates. Although there are occasional and isolated anecdotal reports on social media of alleged incidents of locums seeking higher rates than already agreed, these are far outstripped by reports of pharmacy businesses unwilling to negotiate and who do not want to pay the necessary rate to engage a locum and instead have set capped or fixed rates,” said the PDA.

It added that all parties should honour agreements they enter into, including a pharmacy’s commitment to the NHS that it will open at set times to provide pharmaceutical services to patients and the public.

The organization reiterated that it will request an investigation by the Competition and Markets Authority if there was evidence to support a finding that two or more pharmacy businesses had colluded together to set a maximum rate they will pay locums. The PDA has revealed that it has got feedback from locums that some 'unrelated pharmacy businesses' in the same area all have the same capped maximum locum rate.

PDA also explained that a “blacklist” requires creating and maintaining a record containing individuals’ data. “The list owner must consider that everyone responsible for using personal data must follow strict rules called ‘data protection principles.”

“It is unclear how those businesses having discussions about creating a blacklist believe the above rules and rights would be met. This includes how a locum would be notified of their inclusion on a list and the reasons that justified it,” the organization noted.

The PDA also stated that the Employment Relations Act 1999 (Blacklisting) Regulations 2010 penalize the listing of trade union members for the purpose of discrimination against them. Under the regulations:

  • It is unlawful for anyone to compile, supply, sell or use a ‘prohibited list’
  • It is unlawful for an employer to refuse employment to a job applicant, to dismiss an employee, or to subject an employee to any other detriment for a reason related to a ‘prohibited list’
  • It is unlawful for an employment agency to refuse to provide its services to an individual for a reason related to a ‘prohibited list’.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less